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In a previous study, we found that type I collagen activates human
polymorphonuclear neutrophils by binding to a membrane integrin [31.
The activation depends on two sequences, both contained in the al(I)
CB6 peptide, one is RGD, starting at residue 915, and the second is
DGGRYY, starting at residue 1034 of the al(I) chain. We checked the
effect of several other types of collagens, principally type JV collagen
from several origins. The basement membrane from bovine lens as well
as type IV collagen prepared from it by tartaric acid extraction did not
activate the human neutrophils. In contrast, when neutrophils had been
previously in contact with type IV collagen their activation by type I or
the al(I) CB6 peptide, or the bacterial peptide N-formyl-methionyl-
leucyl-phenylalanine, was inhibited. This effect was abolished when
type IV collagen had been previously treated by pepsin. On the other
hand, the fractions of type IV collagen that resisted digestion by
bacterial collagenase still exhibited this inhibiting effect. This effect
probably explains the physiological property of neutrophils to cross
vascular walls without being activated.
Previous work from this laboratory showed that type I
collagen is able to bind and activate polymorphonuclear neu-
trophils (PMN) [1—3]. The present paper addresses the follow-
ing questions: (1) dO basement membrane type IV collagen,
laminin and other components of basement membrane also
activate PMN? Neutrophils have to cross basement membrane
when they are chemoattracted toward the inflamed areas. (2)
Does this moving represent a first step in their activation
process? (3) How is basement membrane protected from pre-
mature digestion by the products of secretion from PMN?
Methods
Human PMN are prepared by a single step centrifugation
procedure through a metrizoate-polyprep gradient [2]. The
adhesion of PMN to proteins is evaluated in 96-well plastic
plates. The wells are covered with the protein to be studied.
PMN suspensions are added and incubated for 30 minutes.
Then, the non-adherent cells are counted. Also, the adherent
cells may be stained with crystal violet and their number
measured by densitometry.
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Activation of PMN is evaluated by measurement of the
production of 02 by the ferricytochrome c reduction in test
tubes [1].
Several preliminary experiments have shown that type IV
collagen has no direct effects on the PMN activation but that it
confers these cells a state of low-response to other stimuli. To
study this "negative-priming", we devised experiments divided
into two consecutive phases. The PMN suspension was first
incubated for 30 minutes in test tubes, with convenient amounts
of type IV collagen or with its fractions having resisted proteo-
lytic digestion. Then, PMN were transferred to a second
incubation medium containing an activating agent such as fmlp,
PMA or type I collagen. The production of O2 was measured
for 15 minutes in this medium through ferricytochrome c
reduction.
Type IV collagen was obtained in a very pure form by
extraction of bovine lens anterior capsule with 0.1 M solution of
tartaric acid (100 ml per 220 capsules) [4]. The clear supernatant
was fractionated on a DEAE cellulose column equilibrated with
50 mM tris HC1 buffer pH 8.3 containing 6 M urea [5] (Fig. 1).
The yield was 44 mg of type IV collagen from 220 capsules. A
fraction of this collagen was digested with pepsin at 4°C for 16
hours (molar ratio 1/100) and another part was digested with
purified bacterial collagenase. In the latter case, the non-
collagenous domain was fractionated on S-300 Sephacryl gel [6]
giving a pure NC1 fraction (Fig. 2). Purified EHS tumor type IV
collagen was a gift from Dr. N.A. Kefalides (Philadelphia).
EHS tumor laminin was provided by Dr. J.M. Tournier (Re-
ims). Human blood fibronectin was purchased from Sigma. All
usual reagents were analytical grade from Prolabo (Paris) or
Merck (Darmstadt).
Results
The purity of type IV collagen is shown by SDS-PAGE
electrophoresis (Fig. 1) and that of the NC1 fraction is shown on
Figure 2.
Figure 3 shows that PMN adhered with different affinities to
the constituents of basement membrane that we studied. Lami-
nm bound PMN to a higher extent than any other protein.
Figure 4 shows that none of the samples of either type IV
collagen (nonpepsinized), laminin or fibronectin, was able to
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Fig. 1. Preparation of type IV collagen from bovine anterior lens capsule. SDS-PAGE analysis of the different fractions: A: non-reducing
conditions; B: type I collagen (control); C: after reduction with dithiotreitol. I: tartaric acid extract; 2: peak 1; 3: peak 2.
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Fig. 2. Preparation of the NC I fraction from bovine anterior lens capsule type IV collagen.
directly stimulate PMN. On the other hand, unpepsinized type gen, they already exhibited decreased responses to either fmlp,
I collagen acted positively. PMA or type I collagen stimulations (Fig. 5, A, B). The purified
After PMN were incubated with bovine lens type IV colla- NC1 domain had an even more intensive inhibiting effect (Fig.
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Fig. 3. Adhesion of human neutrophils to various substrates evaluated
in percentage of the initial number of 5.10' neutrophuls per tube,
suspended in Du!becco's medium. l-BSA; 2-Type I collagen; 3-EHS-
tumor type IV collagen; 4-Bovine lens capsule type IV collagen; 5-Same
as 4 treated with pepsin; 6-EHS-tumor laminin.
SC). On the other hand, after treatment of type IV collagen with
pepsin, the resistant helical region had no influence on fmlp and
PMA activation, whereas it enhanced the activation by type I
collagen. Laminin and fibronectin were devoid of inhibiting
effects (Fig. 5, E and F).
The effects of the NC! domain persisted even after heat
denaturation or reduction by niercaptoethanol. The intensity of
the negative priming induced by the first incubation with type
IV collagen depended on the nature of the stimulus applied
during the second incubation. PMA stimulation was better
preserved than that induced by fmlp or type I collagen (Fig. 6).
The response to the inhibiting type IV collagen was grossly
dose-dependent. We found that, by performing second incuba-
tions for times varying from 15 to 90 minutes, the negative
priming period lasted from 45 to 75 minutes (Fig. 7).
Discussion
PMN circulate in the blood. When a tissue area exhibits an
inflammatory reaction, these PMN are chemoattracted. They
marginate on the endothelial cells, then move through the
vascular wall and invade the inflamed tissue. During their
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Fig. 4. Formation of 02 by neutrophils as evaluated by measuring the
increase in absorbance at 550 nm produced by ferricytochrome c
reduction. 1-USA; 2-fmlp; 3-Bovine type I collagen; 4-EHS-tumor type
IV collagen; 5-Bovine lens capsule type IV collagen; 6-Same as 5
treated with pepsin; 7-El-IS-tumor laminin.
Fig. 5. Effect of pretreatment of neutrophils
by various fractions of type lv collagen.
Pretreatment with: A: saline; B: bovine lens
type IV collagen (100 zgJml); C: NC 1 domain
from bovine type IV collagen (100 ig/ml); D:
pepsinized bovine lens type IV collagen (100
sg/ml; E: laminin from EHS tumor (100 sgJ
ml); F: human blood fibronectin (100 igIml).
Second incubation was with: 1: saline; 2: 8 nsi
PMA; 3: 0.5 LM fmlp; 4: 0.3 /.LM type I
collagen. Statistical calculations: *decrease
significant at P < 0.05, **decrease significant
at P C 0.001, 5tincrease significant at P C
0.05, NS: not significant variation.
moving through the basement membrane, they bind temporarily
to the molecules that constitute it. If this binding were capable
of activating PMN, there would be a premature activation of
these cells and they would destroy the vessel wall at distance
from the inflamed area, increasing the wasted-zone without any
profit.
The fact that basement membrane collagen induces a nega-
tive priming on PMN is new and relevant because it permits
these cells to completely migrate up to the inflamed zones prior
to becoming activated. Such a phenomenon clearly protects
normal tissues. A somewhat analogous effect exerted by com-
plete basement membrane has also been published [7]. On the
other hand, when basement membrane is degraded, in the
inflamed areas, all the more or less degraded and denatured
protein molecules participate in the activation of PMN. De-
graded type IV collagen by its helical domain is able to
participate to this activation phenomenon.
There remains to find out what are the particular sequences in
the NC! domain responsible for the negative priming effect and
in the helical part, responsible for the activation of PMN.
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Fig. 6. Relationship between the amount of bovine lens capsule bm
collagen added to PMN and the intensity of negative priming. Pretreat-
ment of neutrophils with increasing concentrations of NC! domain from
bovine lens type IV collagen. The second incubation was with: 8 nM
PMA (•); 0.5 M fmlp (S); 0.3 sM type I collagen (A).
Reprint requests to Jacques P. Borel, M.D., Laboratory of Biochem-
istry, URA CNRS 610, University of Reims, 51 Rue Cognacq Jay,
F51095 Reims, France.
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